Christopher Duymich

Christopher Duymich is an accomplished CMC and product development leader with a focus on guiding assets through phase-appropriate pharmaceutical product development. Currently serving as the Director of CMC Project Management at Abcuro, Inc., they aim to create transformative cures for patients with unmet medical needs, particularly in rare diseases and oncology. Christopher has previously held vital roles at companies such as CSL Behring and DxTerity, where they led teams in analytical process transfers and diagnostic test validations. They earned a B.S. in Biochemistry from Alma College and a PhD in Genetic, Molecular, and Cellular Biology from the University of Southern California.